Erasca, Inc. - Common Stock (ERAS)

Historical Holders from Q3 2021 to Q3 2025

Symbol
ERAS on Nasdaq
CUSIP
29479A108
Type / Class
Equity / Common Stock
Shares outstanding
283M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
215M
Holdings value
$469M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
139
Number of buys
55
Number of sells
-60
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Erasca, Inc. - Common Stock (ERAS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 7.2% $28.9M 20.3M T. Rowe Price Investment Management, Inc. Jun 30, 2025
Frazier Life Sciences Public Fund, L.P. 5.3% -33.8% $21.4M -$10.7M 15M -33.4% Frazier Life Sciences Public Fund, L.P. Jun 30, 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 5.1% +17.5% $20.6M $3.11M 14.5M +17.8% Suvretta Capital Management, LLC Jun 30, 2025
Logos Global Management LP 4.8% -10% $29.6M -$3.27M 13.6M -9.93% Logos Global Management LP Sep 30, 2025
NOVARTIS PHARMA AG 4.4% $17.1M 12.3M Novartis Pharma AG Dec 31, 2024

Institutional Holders of Erasca, Inc. - Common Stock (ERAS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 215M $469M -$3.52M $2.18 139
2025 Q2 218M $277M -$8.2M $1.27 141
2025 Q1 224M $307M -$9.73M $1.37 151
2024 Q4 231M $579M -$3.89M $2.51 144
2024 Q3 232M $633M +$46.9M $2.73 130
2024 Q2 204M $480M +$312M $2.36 124
2024 Q1 72.7M $150M +$6.87M $2.06 105
2023 Q4 69.2M $148M -$3.99M $2.13 115
2023 Q3 71.3M $140M -$6.33M $1.97 106
2023 Q2 74.3M $205M -$10.9M $2.76 109
2023 Q1 78M $235M -$11.5M $3.01 114
2022 Q4 79.8M $344M +$2.8M $4.31 104
2022 Q3 80.5M $628M +$33.8M $7.80 85
2022 Q2 76.9M $428M +$22M $5.57 86
2022 Q1 72.8M $626M +$45.2M $8.60 79
2021 Q4 63.7M $988M +$64.7M $15.58 63
2021 Q3 44.1M $919M +$919M $21.22 53